slides · global inventory
Analyze Data
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 58,039
Current window 33,151-33,180
Pages 1,935
Rows per page 30
Slide function
33,151-33,180 of 58,039
10
The chart displays revenue in millions for Q1, Q2, and Q3 of 2022.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
13
Includes Y/Y growth percentages and margin percentages for each year.Advantage Solutions | Investor Presentation Deck | 25 slides · Advantage Solutions
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
05
Revenue chart is a stacked bar chart; Gross Profit chart is a combo chart with bars for profit and dots for margin percentage.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
06
Operating Expenses chart is a stacked bar chart showing OpEx vs SBC + Non-Recurring expenses.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
08
The advertising spend chart shows percentage decreases quarter-over-quarter.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
11
Includes footnotes explaining financial income and non-recurring expenses.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations 1 hit
12
The slide shows a significant increase in Norepinephrine levels with Ampreloxetine treatment compared to placebo.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
13
Study 0169 data showing significant increases in Norepinephrine and decreases in DHPG across three patient cohorts.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Aha Moment1 hit
14
The chart illustrates a worsening of blood pressure in the placebo group compared to the treatment group.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Before After1 hit
15
The slide uses a bar chart with error bars to show treatment effects. 'Worsening' is indicated by a downward arrow on the right.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Before After1 hit
22
The slide provides a standard 'Table 1' style clinical trial baseline characteristic summary.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
23
The slide shows patient counts and percentages for study completion and various reasons for discontinuation.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
24
The slide uses a forest plot to visualize the odds ratio (0.60) with a 95% confidence interval (0.27, 1.29) crossing the null value of 1.0.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
26
The slide highlights the MSA subgroup with a blue box, suggesting a focus on this specific finding.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · KPI Overview1 hit
27
The slide uses forest plots to compare treatment effects (ampreloxetine vs placebo) across different patient populations (Overall, MSA, PD, PAF).Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · KPI Overview1 hit
28
The slide includes a table of adverse events and bulleted takeaways regarding clinical safety parameters.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
37
The slide provides a summary of patient characteristics to demonstrate baseline comparability.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
38
The chart uses a split-axis design to represent different study periods (Study 0169 and 0170).Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
39
The chart uses a split-axis design to represent three distinct study phases (0169, 0170 OL, 0170 RW).Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
40
The chart uses a forest plot format to visualize confidence intervals for multiple clinical endpoints.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
41
The chart uses a randomized withdrawal (RW) design to isolate the effect of drug discontinuation.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
42
The slide includes a footnote defining abbreviations and study parameters.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
05
The slide uses a process-style arrow diagram to present three core financial metrics.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
09
The chart displays quarterly financial performance metrics for Vivid Seats.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
10
Includes margin percentages overlaid on bar charts.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
11
The slide highlights a strong balance sheet with $274M cash and $274M debt, plus an undrawn $100M credit facility.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
12
The table uses arrows to indicate the direction of guidance revisions (upward or flat).Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
17
Includes a footnote regarding the absence of EPS data prior to October 18, 2021.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations 1 hit
18
The chart highlights specific quarters in blue (Q3 2019, Q3 2021, Q3 2022), likely to denote seasonality or specific comparison periods.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations 1 hit
19
The table includes both absolute dollar values and percentage margins for each quarter.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations 1 hit